NCT05514899View on ClinicalTrials.gov

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
HIVCannabisTHCNeuroinflammatory DiseaseNeuroinflammatory ResponseMicrobiome
Interventions
DRUG

THC

THC capsule

DRUG

CBD

oral solution

Trial Locations (1)

92103

RECRUITING

HIV Neurobehavioral Research Program (HNRP), San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER